Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population

Mark J Gallardo,1,2 Richard A Supnet,1 Jane Ellen Giamporcaro,3 Dana M Hornbeak3 1El Paso Eye Surgeons, PA, El Paso, 2Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 3Division of Clinical Research and Medical Affairs, Glaukos Corporation, Lagun...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gallardo MJ, Supnet RA, Giamporcaro JE, Hornbeak DM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
IOP
Acceso en línea:https://doaj.org/article/41c753f8f5574b6ea18080cfd6fc6f47
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:41c753f8f5574b6ea18080cfd6fc6f47
record_format dspace
spelling oai:doaj.org-article:41c753f8f5574b6ea18080cfd6fc6f472021-12-02T00:17:36ZOutcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population1177-5483https://doaj.org/article/41c753f8f5574b6ea18080cfd6fc6f472016-10-01T00:00:00Zhttps://www.dovepress.com/outcomes-of-combined-trabecular-micro-bypass-and-phacoemulsification-i-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Mark J Gallardo,1,2 Richard A Supnet,1 Jane Ellen Giamporcaro,3 Dana M Hornbeak3 1El Paso Eye Surgeons, PA, El Paso, 2Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 3Division of Clinical Research and Medical Affairs, Glaukos Corporation, Laguna Hills, CA, USA Purpose: The purpose of this study was to evaluate intraocular pressure (IOP) and topical ocular hypotensive medication burden at 12 months postoperatively in a predominantly Hispanic patient population with primary open-angle glaucoma each implanted with one trabecular micro-bypass stent during cataract surgery.Methods: This was a retrospective, consecutive case series. The main objective was to assess reduction of IOP and/or medication burden in all eyes at the 12-month postoperative exam. A secondary objective was to assess outcomes in 3 subgroups, distinguished preoperatively by IOP control and by medication burden (suboptimal or maximum therapy) and with different treatment goals. Group 1 had medication-controlled IOP and goal to reduce medications while maintaining IOP control (n=65); Group 2 had uncontrolled IOP on ≤2 medications and goal to reduce IOP and maintain/reduce medication burden (n=31); and Group 3 had uncontrolled IOP on ≥3 medications and goal to reduce IOP and avoid filtering surgery (n=38). Evaluations included IOP, medication use, cup-to-disc ratio, visual fields, complications, and interventions. One hundred subjects (134 eyes) have been followed for 12 months.Results: Most patients (80%) were Hispanic and had moderate or severe glaucoma (87%). At 12 months, mean IOP reduced to 12.9 mmHg vs 16.5 mmHg preoperatively; 92% had an IOP ≤15 mmHg at 12 months (99% had ≤18 mmHg). Mean medication burden had decreased to 0.9 vs 2.3 preoperatively. At the 12-month time point, 94% of all eyes achieved their predefined treatment goal of reduced IOP and/or medications. Reductions in medication burden for Group 1, and in IOP for Groups 2 and 3, were highly statistically significant (P<0.001). Two eyes in Group 3 had filtering surgery; the remaining 95% avoided such treatment. No other complications were reported.Conclusion: This mainly Hispanic population with predominantly moderate or severe glaucoma had substantial reduction of IOP and medication and favorable safety for 12 months following stent implantation during cataract surgery, with treatment success achieved in all 3 subgroups. These data show this stent technology to be effective in Hispanic eyes with more advanced disease. Keywords: glaucoma, trabecular micro-bypass, Hispanic, micro-invasive glaucoma surgery, IOPGallardo MJSupnet RAGiamporcaro JEHornbeak DMDove Medical Pressarticleglaucomatrabecular micro-bypassHispanicMIGSIOPOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 10, Pp 1931-1937 (2016)
institution DOAJ
collection DOAJ
language EN
topic glaucoma
trabecular micro-bypass
Hispanic
MIGS
IOP
Ophthalmology
RE1-994
spellingShingle glaucoma
trabecular micro-bypass
Hispanic
MIGS
IOP
Ophthalmology
RE1-994
Gallardo MJ
Supnet RA
Giamporcaro JE
Hornbeak DM
Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population
description Mark J Gallardo,1,2 Richard A Supnet,1 Jane Ellen Giamporcaro,3 Dana M Hornbeak3 1El Paso Eye Surgeons, PA, El Paso, 2Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 3Division of Clinical Research and Medical Affairs, Glaukos Corporation, Laguna Hills, CA, USA Purpose: The purpose of this study was to evaluate intraocular pressure (IOP) and topical ocular hypotensive medication burden at 12 months postoperatively in a predominantly Hispanic patient population with primary open-angle glaucoma each implanted with one trabecular micro-bypass stent during cataract surgery.Methods: This was a retrospective, consecutive case series. The main objective was to assess reduction of IOP and/or medication burden in all eyes at the 12-month postoperative exam. A secondary objective was to assess outcomes in 3 subgroups, distinguished preoperatively by IOP control and by medication burden (suboptimal or maximum therapy) and with different treatment goals. Group 1 had medication-controlled IOP and goal to reduce medications while maintaining IOP control (n=65); Group 2 had uncontrolled IOP on ≤2 medications and goal to reduce IOP and maintain/reduce medication burden (n=31); and Group 3 had uncontrolled IOP on ≥3 medications and goal to reduce IOP and avoid filtering surgery (n=38). Evaluations included IOP, medication use, cup-to-disc ratio, visual fields, complications, and interventions. One hundred subjects (134 eyes) have been followed for 12 months.Results: Most patients (80%) were Hispanic and had moderate or severe glaucoma (87%). At 12 months, mean IOP reduced to 12.9 mmHg vs 16.5 mmHg preoperatively; 92% had an IOP ≤15 mmHg at 12 months (99% had ≤18 mmHg). Mean medication burden had decreased to 0.9 vs 2.3 preoperatively. At the 12-month time point, 94% of all eyes achieved their predefined treatment goal of reduced IOP and/or medications. Reductions in medication burden for Group 1, and in IOP for Groups 2 and 3, were highly statistically significant (P<0.001). Two eyes in Group 3 had filtering surgery; the remaining 95% avoided such treatment. No other complications were reported.Conclusion: This mainly Hispanic population with predominantly moderate or severe glaucoma had substantial reduction of IOP and medication and favorable safety for 12 months following stent implantation during cataract surgery, with treatment success achieved in all 3 subgroups. These data show this stent technology to be effective in Hispanic eyes with more advanced disease. Keywords: glaucoma, trabecular micro-bypass, Hispanic, micro-invasive glaucoma surgery, IOP
format article
author Gallardo MJ
Supnet RA
Giamporcaro JE
Hornbeak DM
author_facet Gallardo MJ
Supnet RA
Giamporcaro JE
Hornbeak DM
author_sort Gallardo MJ
title Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population
title_short Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population
title_full Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population
title_fullStr Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population
title_full_unstemmed Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population
title_sort outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly hispanic patient population
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/41c753f8f5574b6ea18080cfd6fc6f47
work_keys_str_mv AT gallardomj outcomesofcombinedtrabecularmicrobypassandphacoemulsificationinapredominantlyhispanicpatientpopulation
AT supnetra outcomesofcombinedtrabecularmicrobypassandphacoemulsificationinapredominantlyhispanicpatientpopulation
AT giamporcaroje outcomesofcombinedtrabecularmicrobypassandphacoemulsificationinapredominantlyhispanicpatientpopulation
AT hornbeakdm outcomesofcombinedtrabecularmicrobypassandphacoemulsificationinapredominantlyhispanicpatientpopulation
_version_ 1718403795770146816